VERRICA PHARMACEUTICALS INC
(NASDAQ: VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

6.800

-0.050 (-0.73%)
Range - - -   (-%)
Open -
Previous Close 6.850
Bid Price 6.000
Bid Volume 13
Ask Price 6.200
Ask Volume 9
Volume 114,880
Value -
Remark
Delayed prices. Updated at 25 Apr 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis